Morgan Adam
CIK 1964335 · View on SEC EDGAR ↗
First SEC filing: March 2, 2026 · Latest: March 2, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 8, 2025 | HRTX | P | 70,012 | $15.00 | $1,050,180 | 70,012 Indirect | — | Acquired | -97.9% (price as of 2026-08-20) |
| Aug. 8, 2025 | HRTX | P | 1,766,546 | $1.50 | $2,649,819 | 8,753,290 Indirect | +25.28% | Acquired | -78.8% (price as of 2026-08-20) |
| July 21, 2023 | HRTX | P | 1,162,891 | $1.37 | $1,593,161 | 1,162,891 Indirect | — | Acquired | -76.8% (price as of 2026-08-20) |
| July 21, 2023 | HRTX | P | 2,486,744 | $1.37 | $3,406,839 | 6,986,744 Indirect | +55.26% | Acquired | -76.8% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 8, 2025 | HRTX | Series A Convertible Preferred Stock [F3] | Common Stock | — | — | 70,012 | Acquired |
| Jan. 31, 2025 | HRTX | Stock Option (Right to Buy) | Common Stock (35,900) | $1.70 | Jan. 31, 2035 | 35,900 | Acquired |
| Jan. 30, 2025 | HRTX | Stock Option (Right to Buy) | Common Stock (35,900) | $1.73 | Jan. 30, 2035 | 35,900 | Acquired |
| Jan. 19, 2024 | HRTX | Stock Option (Right to Buy) | Common Stock (83,685) | $2.09 | Jan. 19, 2034 | 83,685 | Acquired |
| July 21, 2023 | HRTX | Pre-funded Warrants to Purchase Common Stock | Common Stock, par value $0.01 per share (1,162,891) | $0.00 | — | 1,162,891 | Acquired |
| Feb. 22, 2023 | HRTX | Stock Option (Right to Buy) | Common Stock (227,272) | $2.70 | Feb. 22, 2033 | 227,272 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).